Advanced Enzyme Technologies Limited — Investor Meet, 07-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

**Advanced Enzyme Technologies Q3 & 9M FY26 Update:**

**Financials:** Q3 revenue rose 2% YoY to INR 171.9 Cr; PAT up 11% to INR 43.2 Cr. 9M revenue grew 15% to INR 542.4 Cr, PAT 20% to INR 128.4 Cr. Human Healthcare saw Q3 decline due to US market uncertainty/tariffs, but Animal Healthcare and Bioprocessing showed strong growth.

**Outlook & Strategy:** Management targets 13-15% continuous double-digit growth over 3-5 years. A new R&D center in Nashik (Q2 next FY) will boost novel product development. The B2C business is expanding. Despite market disruptions, the long-term outlook is positive, with increasing US inquiries signaling future strength.